BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32416867)

  • 1. Discovery and pharmacology of the covalent GLP-1 receptor (GLP-1R) allosteric modulator BETP: A novel tool to probe GLP-1R pharmacology.
    Willard FS; Ho JD; Sloop KW
    Adv Pharmacol; 2020; 88():173-191. PubMed ID: 32416867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles.
    Bueno AB; Showalter AD; Wainscott DB; Stutsman C; Marín A; Ficorilli J; Cabrera O; Willard FS; Sloop KW
    J Biol Chem; 2016 May; 291(20):10700-15. PubMed ID: 26975372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of the innate electrophilicity of 4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a small-molecule positive allosteric modulator of the glucagon-like peptide-1 receptor.
    Eng H; Sharma R; McDonald TS; Edmonds DJ; Fortin JP; Li X; Stevens BD; Griffith DA; Limberakis C; Nolte WM; Price DA; Jackson M; Kalgutkar AS
    Drug Metab Dispos; 2013 Aug; 41(8):1470-9. PubMed ID: 23653442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a potential positive allosteric modulator of glucagon-like peptide 1 receptor through virtual screening and experimental study.
    Redij T; Ma J; Li Z; Hua X; Li Z
    J Comput Aided Mol Des; 2019 Nov; 33(11):973-981. PubMed ID: 31758355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification.
    Nolte WM; Fortin JP; Stevens BD; Aspnes GE; Griffith DA; Hoth LR; Ruggeri RB; Mathiowetz AM; Limberakis C; Hepworth D; Carpino PA
    Nat Chem Biol; 2014 Aug; 10(8):629-31. PubMed ID: 24997604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allostery.
    Koole C; Wootten D; Simms J; Miller LJ; Christopoulos A; Sexton PM
    J Pharmacol Exp Ther; 2015 Apr; 353(1):52-63. PubMed ID: 25630467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput FRET assays for cAMP.
    Chepurny OG; Matsoukas MT; Liapakis G; Leech CA; Milliken BT; Doyle RP; Holz GG
    J Biol Chem; 2019 Mar; 294(10):3514-3531. PubMed ID: 30622136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New screening strategy and analysis for identification of allosteric modulators for glucagon-like peptide-1 receptor using GLP-1 (9-36) amide.
    Nakane A; Gotoh Y; Ichihara J; Nagata H
    Anal Biochem; 2015 Dec; 491():23-30. PubMed ID: 26341912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of small molecule positive allosteric modulators of the secretin receptor.
    Dengler DG; Harikumar KG; Pollari S; Sun Q; Brown BT; Shinoki-Iwaya A; Ardecky R; Miller LJ; Sergienko EA
    Biochem Pharmacol; 2021 Mar; 185():114451. PubMed ID: 33545115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of an Orally Efficacious Positive Allosteric Modulator of the Glucagon-like Peptide-1 Receptor.
    Willard FS; Wainscott DB; Showalter AD; Stutsman C; Ma W; Cardona GR; Zink RW; Corkins CM; Chen Q; Yumibe N; Agejas J; Cumming GR; Minguez JM; Jiménez A; Mateo AI; Castaño AM; Briere DA; Sloop KW; Bueno AB
    J Med Chem; 2021 Mar; 64(6):3439-3448. PubMed ID: 33721487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule allosteric modulation of the glucagon-like Peptide-1 receptor enhances the insulinotropic effect of oxyntomodulin.
    Willard FS; Wootten D; Showalter AD; Savage EE; Ficorilli J; Farb TB; Bokvist K; Alsina-Fernandez J; Furness SG; Christopoulos A; Sexton PM; Sloop KW
    Mol Pharmacol; 2012 Dec; 82(6):1066-73. PubMed ID: 22930710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into probe-dependent positive allosterism of the GLP-1 receptor.
    Bueno AB; Sun B; Willard FS; Feng D; Ho JD; Wainscott DB; Showalter AD; Vieth M; Chen Q; Stutsman C; Chau B; Ficorilli J; Agejas FJ; Cumming GR; Jiménez A; Rojo I; Kobilka TS; Kobilka BK; Sloop KW
    Nat Chem Biol; 2020 Oct; 16(10):1105-1110. PubMed ID: 32690941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two small molecule agonists of glucagon-like peptide-1 receptor modulate the receptor activation response differently.
    Cheong YH; Kim MK; Son MH; Kaang BK
    Biochem Biophys Res Commun; 2012 Jan; 417(1):558-63. PubMed ID: 22177947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R).
    Méndez M; Matter H; Defossa E; Kurz M; Lebreton S; Li Z; Lohmann M; Löhn M; Mors H; Podeschwa M; Rackelmann N; Riedel J; Safar P; Thorpe DS; Schäfer M; Weitz D; Breitschopf K
    J Med Chem; 2020 Mar; 63(5):2292-2307. PubMed ID: 31596080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery.
    Harikumar KG; Wootten D; Pinon DI; Koole C; Ball AM; Furness SG; Graham B; Dong M; Christopoulos A; Miller LJ; Sexton PM
    Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18607-12. PubMed ID: 23091034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric Optical Control of a Class B G-Protein-Coupled Receptor.
    Broichhagen J; Johnston NR; von Ohlen Y; Meyer-Berg H; Jones BJ; Bloom SR; Rutter GA; Trauner D; Hodson DJ
    Angew Chem Int Ed Engl; 2016 May; 55(19):5865-8. PubMed ID: 27059784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two distinct domains of the glucagon-like peptide-1 receptor control peptide-mediated biased agonism.
    Lei S; Clydesdale L; Dai A; Cai X; Feng Y; Yang D; Liang YL; Koole C; Zhao P; Coudrat T; Christopoulos A; Wang MW; Wootten D; Sexton PM
    J Biol Chem; 2018 Jun; 293(24):9370-9387. PubMed ID: 29717000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Aminothiophene derivatives as a new class of positive allosteric modulators of glucagon-like peptide 1 receptor.
    Redij T; McKee JA; Do P; Campbell JA; Ma J; Li Z; Miller N; Srikanlaya C; Zhang D; Hua X; Li Z
    Chem Biol Drug Des; 2022 Jun; 99(6):857-867. PubMed ID: 35313084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric Modulators Enhancing GLP-1 Binding to GLP-1R via a Transmembrane Site.
    Wang J; Yang D; Cheng X; Yang L; Wang Z; Dai A; Cai X; Zhang C; Yuliantie E; Liu Q; Jiang H; Liu H; Wang MW; Yang H
    ACS Chem Biol; 2021 Nov; 16(11):2444-2452. PubMed ID: 34570476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Characterisation of Small Molecule Agonists Effect on the Human Glucagon Like Peptide-1 Receptor Internalisation.
    Thompson A; Stephens JW; Bain SC; Kanamarlapudi V
    PLoS One; 2016; 11(4):e0154229. PubMed ID: 27100083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.